On BSE, the stock ended the day at Rs 708.25, up 3.61 per cent from the previous close. Intra-day, it touched a high of Rs 728.45.
The scrip settled the day on NSE at Rs 706.55, up 3.46 per cent from the previous close. It touched a high of Rs 729.05 during the intra-day trade.
Following an uptick in the counter, the market capitalisation of the firm stood nearly at Rs 1.7 lakh crore.
"This proposed action will clear the path for Sun Pharma to supply approved products from the Mohali facility to the US market, subject to normal USFDA regulatory requirements," it added.
Disclaimer: No Business Standard Journalist was involved in creation of this content